As the summer of 2019 drew to a close, the cannabis industry fixated on a rash of illnesses linked to vaping products. The focus has only grown more pronounced. As of Oct. 22, the Centers for Disease Control and Prevention had reported more than 1,400 cases of vaping-related pulmonary disease and at least 33 deaths.
While the illnesses are linked to vaping products (and increasing in number every day), the science is still a murkier subject. State health officials and independent researchers are grappling with a fundamental problem: If the source of these illnesses is found in the illicit vape market, as investigations indicate, then how can the scientific community and law enforcement effectively prevent the spread of this disease?
What sort of public education responsibility falls to licensed cannabis businesses?
Here, we’re reserving a page on Cannabis Business Times and Cannabis Dispensary’s websites to maintain our record of how this story is unfolding. You’ll find our growing archive of news stories below, and we’ll continually update this page with the latest information and perspectives on this industry problem.
From the CDC:
What is causing this outbreak of lung injury?
If there are questions you’d like to see answered or angles you’d like to share, please email Digital Editor Eric Sandy at email@example.com.
Here are the stories we’ve published on Cannabis Business Times and Cannabis Dispensary to date: